MedTrace Logo

The CPH-MBD Cohort

NCT07193056 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-12-31

No results posted yet for this study

Summary

Persons with chronic kidney disease (CKD) have a 3-fold increased risk of bone fracture and a 10-fold increased risk of cardiovascular disease than the general population. These increased risks are related to the disturbances in the mineral metabolism, and this clinical entity is termed Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD).

The overall aim of the present project is to explore factors that may predict or associate with the development of bone and cardiovascular disease in patients with CKD and hopefully provide insight into underlying mechanisms and pathophysiological pathways for future treatment and prevention.

In a sub study investigators aim to explore the calcium and phosphate balance in patients with CKD and describe how these associate with each other as well as with kidney function (eGFR).

Conditions

  • Chronic Kidney Disease Mineral and Bone Disorder
  • Chronic Kidney Disease (CKD)
  • Bone Markers

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Ditte Hansen, Medical doctor, professor · Department of Nephrology, Herlev Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2055-01-31
Completion
2055-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07193056 on ClinicalTrials.gov